• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home The Classics Emergency Classics

The BHAT: Propranolol after acute myocardial infarction [Classics Series]

byMichael MilliganandAndrew Cheung, MD MBA
July 15, 2016
in Emergency Classics, General Medicine Classics, The Classics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Beta-blockers were commonly used in the treatment of coronary artery disease in the 1980s, though prior studies were inconclusive due to limitations in study design and small sample sizes.

2. This was the first large, randomized trial to demonstrate that propranolol significantly reduced mortality after acute myocardial infarction when compared with placebo.

Original Date of Publication: March 1982

Study Rundown: The Beta-Blocker Heart Attack Trial (BHAT) was established in 1977 to study whether daily administration of propranolol after a myocardial infarction would lead to a reduction in total mortality. Prior to this study, beta-blockers were well known to reduce myocardial oxygen demand and suppress arrhythmias. They were also widely used in the setting of coronary artery disease, although numerous studies exploring this question were inconclusive due to small sample sizes and study design issues.

In summary, patients with recent hospitalization for myocardial infarction experienced significantly lower all-cause mortality when taking propranolol rather than placebo. Moreover, propranolol therapy led to significantly lower rates of cardiovascular mortality and sudden death. Patients taking propranolol experienced significantly higher rates of bronchospasm and diarrhea, but fewer instances of palpitations when compared to placebo. The BHAT was the first large, randomized trial to demonstrate a significant reduction in mortality when treating patients with recent myocardial infarction with a beta-blocker, and beta-blockade remains a staple in the management of acute myocardial infarction.

Click to read the study in JAMA

In-Depth [randomized controlled trial]: The BHAT was a double-blinded, placebo-controlled, randomized trial conducted at 31 institutions in the United States and Canada. Patients were eligible for the study if they were between 30-69 years of age and hospitalized for acute myocardial infarction. Exclusion criteria were having a contraindication to propranolol (marked bradycardia), a history of severe heart failure or asthma, other life-threatening illness, a need for cardiac surgery, or a previous need for beta-blocker therapy. A total of 3837 were enrolled and randomized to treatment with propranolol 40 mg every eight hours or placebo. The propranolol dose was subsequently titrated up to 60 mg or 80 mg every eight hours.

RELATED REPORTS

Severe aortic stenosis is associated with adverse myocardial characteristics like poor myocardial flow reserve

β-2 agonist exposure in utero linked to autism

Vasodilators associated with increased risk of age-related macular degeneration

The majority of patients enrolled in this study were white males, comprising over 80% of the study population. Compared with patients who received placebo, those in the propranolol group experienced significantly lower all-cause mortality (7.2% vs. 9.8%, p < 0.005). Patients taking propranolol also experienced significantly lower cardiovascular mortality (6.6% vs. 8.9%, p < 0.01), arteriosclerotic heart disease mortality (6.2% vs. 8.5%, p < 0.01), and sudden death (3.3% vs. 4.6%, p < 0.05) compared to those treated with placebo.

There were significantly more instances of bronchospasm (31.3% vs. 27.0%, p < 0.005) and diarrhea (5.5% vs. 3.6%, p < 0.01) in the propranolol group, though palpitations were more common in the placebo group (10.8% vs. 15.1%, p < 0.001).

Image: PD

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Beta-blockersbhatmyocardia
Previous Post

Olanzapine may reduce nausea symptoms for patients on chemotherapy

Next Post

Migraines associated with an increased risk of cardiovascular events in women

RelatedReports

Rilonacept may lower pericarditis recurrence in patients with relapsing pericarditis
Cardiology

Severe aortic stenosis is associated with adverse myocardial characteristics like poor myocardial flow reserve

September 22, 2021
β-2 agonist exposure in utero linked to autism
Neurology

β-2 agonist exposure in utero linked to autism

January 6, 2016
Antioxidants, omega-3 lack benefit in age-related macular degeneration
Cardiology

Vasodilators associated with increased risk of age-related macular degeneration

May 2, 2014
Antidepressant may reduce mental stress-induced myocardial ischemia (REMIT Trial)
Cardiology

Perioperative beta-blocker use beneficial in select cardiovascular subgroups

March 4, 2014
Next Post
Migraines associated with an increased risk of cardiovascular events in women

Migraines associated with an increased risk of cardiovascular events in women

Factors contributing to parents providing alcohol sips to adolescents

Frequent binge drinking associated with lower AMH in African-American women

Parents desensitized with increasing exposure to movie violence/sex

AAP supports mindfulness of children’s media consumption

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Vitamin and mineral supplementation associated with minimal to no benefit in the primary preventing of cardiovascular disease and cancer – US Preventative Services Task Force
  • RSVpreF vaccine prevents symptomatic respiratory syncytial virus infection
  • Incidence of Kawasaki disease found to be lower during the COVID-19 pandemic in the United States
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.